Domestic Hydrogen Inhalation Devices with Integrated PEM Electrolysers: Principles, System Architecture, and Applications

Introduction

The therapeutic potential of molecular hydrogen (H₂) has garnered increasing scientific attention over the past two decades, with over 1,000 peer-reviewed publications documenting its antioxidant, anti-inflammatory, and cytoprotective properties. Hydrogen inhalation therapy, which involves breathing low concentrations of hydrogen gas (typically 1–4% by volume in air), has emerged as a promising modality for various health conditions. To facilitate safe, convenient, and on-demand hydrogen delivery in domestic and clinical settings, compact hydrogen inhalation devices incorporating miniature Proton Exchange Membrane (PEM) electrolysers have been developed. These systems produce medical-grade hydrogen through electrolysis of purified water, ensuring high purity without reliance on pressurised gas cylinders. Whilst residential hydrogen production for therapeutic purposes operates on a substantially smaller scale than industrial applications, adherence to stringent safety, purity, and water quality standards remains paramount.

Working Principles of Miniature PEM Electrolysers

The fundamental electrochemical principles governing miniature PEM electrolysers are identical to their industrial counterparts, albeit with significant differences in scale, materials optimisation, and operational parameters.

Water electrolysis occurs across a proton exchange membrane, typically a perfluorosulphonic acid (PFSA) polymer such as Nafion™, which serves both as a proton conductor and gas separator. At the anode, purified water undergoes oxidation:

$2H_{2}O\to O_2+4H^{+}+4e^{-}$

2H₂O → O₂+4H⁺+4e^-

The generated protons traverse the membrane whilst electrons flow through the external circuit. At the cathode, protons and electrons recombine:

$4H^{+}+4e^{-}\to 2H_2$

4H⁺+4e^- → 2H₂

The net reaction is:

$2H_{2}O\to 2H_2+O_2$

2H₂O → 2H₂+O₂

Miniature PEM electrolysers for hydrogen inhalation devices typically operate at current densities of 0.5–1.5 A/cm², lower than industrial systems, with cell voltages between 1.7 V and 2.0 V. The catalysts employed are platinum-group metals: iridium oxide (IrO₂) at the anode and platinum (Pt) at the cathode, albeit at reduced loadings (0.5–2.0 mg/cm²) compared to industrial systems. The membrane electrode assembly (MEA) active area ranges from 10 to 50 cm², yielding hydrogen production rates of 50–300 millilitres per minute — sufficient for therapeutic inhalation applications.

Complete System Process Flow

Stage 1: Water Source and Pre-filtration

Domestic hydrogen inhalation devices typically utilise mains tap water as the feedstock. The water first passes through a sediment pre-filter (5–10 µm pore size) to remove particulates, rust, and suspended solids that could damage downstream purification components.

Stage 2: Activated Carbon Filtration

Following pre-filtration, the water flows through an activated carbon cartridge to adsorb chlorine, chloramines, volatile organic compounds (VOCs), and taste- and odour-causing substances. This stage is critical for protecting the reverse osmosis membrane and preventing contamination of the electrolyser.

Stage 3: Reverse Osmosis Purification

The water then enters a compact reverse osmosis (RO) module operating at approximately 4–6 bar. The semi-permeable RO membrane rejects dissolved salts, heavy metals, bacteria, and organic molecules, producing permeate with total dissolved solids (TDS) below 10 ppm. A check valve prevents backflow, whilst the concentrate stream is directed to drain.

Stage 4: Deionisation and Final Polishing

Post-RO water passes through a mixed-bed ion exchange resin cartridge or deionisation filter to achieve resistivity above 1.0 MΩ·cm (conductivity below 1.0 µS/cm). This ultra-low conductivity is essential to minimise ionic contamination of the PEM, which would otherwise accelerate membrane degradation and reduce catalyst efficiency.

Stage 5: Water Storage and Temperature Regulation

The purified water is stored in a food-grade polypropylene or borosilicate glass reservoir with capacity typically ranging from 500 ml to 2 litres. Many systems incorporate a thermoelectric cooler or heating element to maintain water temperature within the optimal range of 15–25 °C, thereby stabilising electrolysis efficiency and gas purity.

Stage 6: Electrochemical Hydrogen Generation

A peristaltic or diaphragm pump delivers purified water to the anode chamber of the miniature PEM electrolyser at a controlled flow rate (typically 10–50 ml/min). A switch-mode power supply (SMPS) provides regulated direct current (1–10 A at 3–12 V, depending on stack configuration). Upon energisation, water molecules are split into hydrogen and oxygen gases. The membrane architecture ensures complete gas separation, with hydrogen evolving at the cathode and oxygen at the anode.

Stage 7: Gas-Liquid Separation and Moisture Removal

The hydrogen-rich stream exits the cathode compartment as a gas-liquid mixture and enters a compact gas-liquid separator utilising gravitational or cyclonic separation principles. Separated water returns to the reservoir via a recirculation loop. The humid hydrogen gas then passes through a hydrophobic membrane or silica gel desiccant cartridge to reduce moisture content to below 80% relative humidity at ambient temperature.

Stage 8: Oxygen Removal and Final Purification

To ensure safety and maximise therapeutic efficacy, trace oxygen (arising from membrane crossover or incomplete separation) must be removed. This is achieved through a palladium catalyst bed operating at ambient temperature, which catalyses the recombination of residual oxygen with hydrogen to form water vapour, subsequently removed by a final desiccant stage. The resulting hydrogen purity typically exceeds 99.5%.

Stage 9: Flow Control and Delivery

The purified hydrogen stream passes through a mass flow controller or needle valve, which regulates the output flow rate (typically 50–300 ml/min). The hydrogen is then mixed with ambient air in a precise ratio (commonly 2–4% H₂ in air) within a mixing chamber before delivery through medical-grade silicone tubing to a nasal cannula for inhalation.

Stage 10: Safety, Monitoring, and Control Systems

A microcontroller-based control system governs all operational parameters, including:

• Water Level Monitoring: Float switches or capacitive sensors detect low water levels and halt operation to prevent dry running.

• Water Quality Sensors: Conductivity probes verify purified water resistivity, with automatic shutdown if thresholds are exceeded.

• Hydrogen Concentration Monitoring: Electrochemical or thermal conductivity sensors ensure hydrogen output remains within safe limits (<4% in air, well below the lower explosive limit of 4%).

• Temperature and Pressure Safeguards: Thermistors and pressure transducers prevent overheating and over-pressurisation.

• User Interface: LCD displays and touch controls allow users to select flow rates, session duration, and view system status.

System Components

A complete domestic hydrogen inhalation device comprises:

1. Water Purification Train: Pre-filter, activated carbon, RO membrane, deionisation cartridge

2. Purified Water Reservoir: 0.5–2 litre capacity with level sensing

3. Miniature PEM Electrolyser Stack: 1–5 cell configuration, 10–50 cm² active area

4. Power Supply: SMPS providing 3–12 VDC at 1–10 A

5. Gas Processing Components: Separator, desiccants, catalyst bed

6. Flow Control and Mixing System: Mass flow controller, mixing chamber

7. Delivery Interface: Medical-grade cannula

8. Control Electronics: Microcontroller, sensors, display, safety interlocks

Applications and Therapeutic Contexts

Hydrogen inhalation therapy has been investigated for numerous applications:

• Oxidative Stress Mitigation: Neutralising hydroxyl radicals in conditions such as ischaemia-reperfusion injury, metabolic syndrome, and neurodegenerative diseases

• Anti-inflammatory Effects: Modulating inflammatory cytokine expression in chronic inflammatory conditions

• Post-exercise Recovery: Reducing lactate accumulation and oxidative damage in athletes

• Cognitive Support: Potential neuroprotective effects in age-related cognitive decline

• Adjunctive Cancer Therapy: Mitigating side effects of chemotherapy and radiotherapy

Regulatory and Safety Considerations

Whilst domestic hydrogen inhalation devices do not fall under EU green hydrogen regulatory frameworks (which govern renewable hydrogen for energy applications), they must comply with:

• Medical Device Regulation (MDR) 2017/745: If marketed for therapeutic purposes

• Low Voltage Directive (LVD) 2014/35/EU: Electrical safety requirements

• EMC Directive 2014/30/EU: Electromagnetic compatibility

• Water quality standards: Ensuring purified water meets or exceeds pharmaceutical-grade specifications

Conclusion

Domestic hydrogen inhalation devices incorporating miniature PEM electrolysers represent an elegant convergence of electrochemical engineering, water purification technology, and therapeutic gas delivery. The complete system process — from tap water purification through on-demand hydrogen generation to controlled inhalation delivery — exemplifies the application of rigorous engineering principles to emerging health technologies. As clinical evidence for hydrogen therapy continues to accumulate, these compact, user-friendly systems may facilitate broader access to molecular hydrogen's potential therapeutic benefits.